89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $856,920 | +50.7% | 55,500 | +85.0% | 0.20% | +51.1% |
| Q2 2023 | $568,500 | +103.4% | 30,000 | +63.5% | 0.13% | +98.5% |
| Q1 2023 | $279,471 | +2095.4% | 18,350 | +1735.0% | 0.07% | +2133.3% |
| Q4 2022 | $12,730 | -9.1% | 1,000 | -60.0% | 0.00% | -25.0% |
| Q3 2022 | $14,000 | -86.4% | 2,500 | -92.2% | 0.00% | -85.2% |
| Q2 2022 | $103,000 | -12.0% | 31,950 | +3.2% | 0.03% | +3.8% |
| Q1 2022 | $117,000 | -56.0% | 30,950 | +52.1% | 0.03% | -52.7% |
| Q4 2021 | $266,000 | -38.4% | 20,350 | -7.7% | 0.06% | -40.2% |
| Q3 2021 | $432,000 | +4.9% | 22,050 | 0.0% | 0.09% | +3.4% |
| Q2 2021 | $412,000 | -4.4% | 22,050 | +21.2% | 0.09% | -7.3% |
| Q1 2021 | $431,000 | +123.3% | 18,200 | +130.4% | 0.10% | +100.0% |
| Q4 2020 | $193,000 | +67.8% | 7,900 | +75.6% | 0.05% | +37.1% |
| Q3 2020 | $115,000 | – | 4,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |